Cytotoxic T lymphocyte responses to wild-type and mutant mouse p53 peptides
Authors:
- 1 March 1997
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 27 (3) , 798-801
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A mouse mutant p53 product recognized by CD4+ and CD8+ T cells.Proceedings of the National Academy of Sciences, 1994
- Tumor-rejection antigens recognized by T lymphocytesCurrent Opinion in Immunology, 1993
- Potential immunogenicity of oncogene and tumor suppressor gene productsCurrent Opinion in Immunology, 1993
- Antitumor and antimetastatic activity of interleukin 12 against murine tumors.Journal of Experimental Medicine, 1993
- In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild‐type p53European Journal of Immunology, 1993
- Peptides Naturally Presented by MHC Class I MoleculesAnnual Review of Immunology, 1993
- H-2Kd-restricted antigenic peptides share a simple binding motif.Journal of Experimental Medicine, 1991
- Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast.Journal of Experimental Medicine, 1991
- p53 Mutations in Human CancersScience, 1991
- Competitor analogs for defined T cell antigens: Peptides incorporating a putative binding motif and polyproline or polyglycine spacersCell, 1990